Orphazyme1,004 DKK 0 %
Orphazyme operates in biochemistry. The company specializes in research and development of unusual diseases where there is a deficiency in the function of heat coke proteins. The technique is based on arimoclomol, which stimulates the production of heat coke proteins in cells that experience increased degrees of stress and toxicity. Diseases that the company's products aim to treat include Gaucher's disease and amyotrophic lateral sclerosis (ALS). The company is headquartered in Copenhagen.